After months of speculation, Tesla has officially carved out a spot on the S&P 500.
For a publicly traded company, it's the ultimate achievement.
After months of speculation, Tesla has officially carved out a spot on the S&P 500.
For a publicly traded company, it's the ultimate achievement.
The S&P 500’s up rather nicely, hitting an all-time closing high, ever since Pfizer and Moderna announced their COVID-19 vaccine news.
But not everyone has yet caught on to all this “pent-up demand” and all the profit opportunities it offers.
Take a look….
It's safe to assume that recovery from the pandemic will impact stocks one way or another.
And as "unique" as this year's been, we can still use Tom Gentile's Money Calendar to draw some conclusions and make predictions about what they're likely to do in the year ahead to help you make some money...
China’s recently adopted an anti-innovation stance with strict implications on its businesses, such as e-commerce giant Alibaba.
But that does NOT mean to dump Alibaba shares.
Instead, Bill Patalon will have us cashing in on this “one-stock wealth machine” no matter what China does next….
The anticipation is palpable... and building fast. We've had three reports on extremely effective upcoming coronavirus vaccines, and each report practically blows the last one out of the water.
First we heard preliminary reports that Pfizer and BioNTech's revolutionary messenger RNA (mRNA) coronavirus vaccine was 90% effective. That was great... until yesterday morning, when the biotechs got back in touch to say the real figure was something closer to 95%. And in the middle, we've heard from Moderna, which is reporting its mRNA vaccine is 94.5% effective.
Every time, stocks have taken off like a shot at the news; vaccines have helped push the Dow back above its February 2020 highs.
Here's the thing... setting aside the six vaccines The New York Times reports are in limited use in China and Russia - about which there are many unanswered questions - there are at least nine more coronavirus vaccines deep in phase 3, large-scale efficacy trials.
And there are no less than 55 more candidates in earlier, phase 1 and 2 trials. Some of these vaccine candidates won't advance, but others almost certainly will - two have already.
That all this has happened in less than a year is an "Apollo moonshot"-like scientific achievement. But that's also a whole lot of concentrated upside potential that could flood the markets and push stocks to almost unthinkable highs.
So I asked Money Morning Chief Investment Strategist Shah Gilani what it all means for us investors...
With so much focus on stocks and vaccines, people have overlooked the fact that we’ve somehow got a big, unexpected housing boom on our hands.
And Andrew’s housing play could be one of your top profit generators in 2021….
Our Andrew Keene likes to stick to a routine, like the seven stocks he trades every weekday before breakfast.
So today, he’s switching it up and bringing you a list of the six stocks you should stay far, far away from, no matter how popular they’ve been… .
Thanks to this week’s Vaccine Jump, nearly every segment of the market was in the green except one: the big “Pandemic Stocks” like Zoom, Clorox, Peloton, and the like.
While these “Pandemic Stocks” will naturally be marginalized once normality returns, it’s not happening anytime soon.
So don’t run with the crowd on this because these emotionally-driven selloffs are handing us a rare profit opportunity….
Pfizer's recent news that their COVID-19 vaccine is 90% effective sent the market (and Pfizer's stock) soaring.
And while those who had already invested in the stock have made a nice return, Tom's going to show you the quick and easy way to almost quadruple your money on it...
The markets have gone ballistic on positive news of a COVID-19 vaccine, but investors are buying in all the wrong places.
Here are the best COVID-18 vaccine stocks to buy…
The bulls are nearly everything we look in the market.
While a couple of things are currently driving the markets higher, one "driver" in particular is pointing at a trade that's too good to pass up.
Today, Tom's going to show you exactly how to make some easy money on it...
Tom has sifted through and narrowed down the biggest moneymaking stocks to play in this post-election profit plan….
The future of e-commerce is looking brighter than ever, thanks to the pandemic and the "stay-at-home" orders back in March.
And now, we're looking at two years' worth of e-commerce growth packed into the next few months with the upcoming holiday season.
And here's how you can cash in on this impressive performance....
As of midday Thursday, we've still got no definitive result from the Nov.
3 election.
Indeed, it's still anyone's game.
And the markets are loving it.
So D.R.
appeared on FOX Business' Varney & Co.
to talk about why stocks were rallying with so much up in the air, and he even named the two stocks he thinks will be truly outstanding performers in this environment...
Unfortunately, the political and personal fault lines in the United States are about as raw and volatile as they've ever been. But that's a subject for another time and place.
As investors, whatever our personal politics or feelings are, now is the time to quickly come to terms with what's happening and what likely will happen in the stock market.
Because despite the market's action yesterday, it has drawn a line of its own - a "line in the sand" - and where your money is in relation to this line will make a big difference.
